Spotify Co-Founder’s Neko Health Raises $260M to Expand AI-Powered Preventative Healthcare to U.S.

The Swedish health tech startup, now valued at $1.7 billion, plans to accelerate its growth and innovation in proactive healthcare services.

Neko Health, co-founded by Spotify's Daniel Ek, raised $260 million in Series B funding led by Lightspeed Venture Partners.
The company, which focuses on AI-driven preventative healthcare, is valued at $1.7 billion following this funding round.
Neko Health plans to expand its operations into the U.S., pending regulatory approval, and invest in further research and development.
Its non-invasive health scans, priced at £299 in the U.K., analyze over 50 million data points to detect potential health risks early.
To date, the startup has conducted 10,000 scans in Stockholm and London and has a waiting list of over 100,000 people.